Hashimoto Hiroyuki, Tamaki Tetsuro, Hirata Maki, Uchiyama Yoshiyasu, Sato Masato, Mochida Joji
Department of Orthopaedic, Tokai University School of Medicine, Isehara, Japan; Muscle Physiology and Cell Biology Unit, Tokai University School of Medicine, Isehara, Japan.
Muscle Physiology and Cell Biology Unit, Tokai University School of Medicine, Isehara, Japan; Department of Human Structure and Function, Tokai University School of Medicine, Isehara, Japan.
PeerJ. 2016 Jul 19;4:e2231. doi: 10.7717/peerj.2231. eCollection 2016.
Background. Significant and/or complete rupture in the musculotendinous junction (MTJ) is a challenging lesion to treat because of the lack of reliable suture methods. Skeletal muscle-derived multipotent stem cell (Sk-MSC) sheet-pellets, which are able to reconstitute peripheral nerve and muscular/vascular tissues with robust connective tissue networks, have been applied as a "bio-bond". Methods. Sk-MSC sheet-pellets, derived from GFP transgenic-mice after 7 days of expansion culture, were detached with EDTA to maintain cell-cell connections. A completely ruptured MTJ model was prepared in the right tibialis anterior (TA) of the recipient mice, and was covered with sheet-pellets. The left side was preserved as a contralateral control. The control group received the same amount of the cell-free medium. The sheet-pellet transplantation (SP) group was further divided into two groups; as the short term (4-8 weeks) and long term (14-18 weeks) recovery group. At each time point after transplantation, tetanic tension output was measured through the electrical stimulation of the sciatic nerve. The behavior of engrafted GFP(+) tissues and cells was analyzed by fluorescence immunohistochemistry. Results. The SP short term recovery group showed average 64% recovery of muscle mass, and 36% recovery of tetanic tension output relative to the contralateral side. Then, the SP long term recovery group showed increased recovery of average muscle mass (77%) and tetanic tension output (49%). However, the control group showed no recovery of continuity between muscle and tendon, and demonstrated increased muscle atrophy, with coalescence to the tibia during 4-8 weeks after operation. Histological evidence also supported the above functional recovery of SP group. Engrafted Sk-MSCs primarily formed the connective tissues and muscle fibers, including nerve-vascular networks, and bridged the ruptured tendon-muscle fiber units, with differentiation into skeletal muscle cells, Schwann cells, vascular smooth muscle, and endothelial cells. Discussion. This bridging capacity between tendon and muscle fibers of the Sk-MSC sheet-pellet, as a "bio-bond," represents a possible treatment for various MTJ ruptures following surgery.
背景。肌腱结合处(MTJ)的显著和/或完全断裂是一种难以治疗的损伤,因为缺乏可靠的缝合方法。骨骼肌来源的多能干细胞(Sk-MSC)片丸能够通过强大的结缔组织网络重建外周神经以及肌肉/血管组织,已被用作一种“生物粘合剂”。方法。从绿色荧光蛋白(GFP)转基因小鼠中获取的Sk-MSC片丸,经7天的扩增培养后,用乙二胺四乙酸(EDTA)分离以维持细胞间连接。在受体小鼠的右胫前肌(TA)制备完全断裂的MTJ模型,并用片丸覆盖。左侧作为对侧对照保留。对照组接受等量的无细胞培养基。片丸移植(SP)组进一步分为两组,即短期(4 - 8周)和长期(14 - 18周)恢复组。在移植后的每个时间点,通过电刺激坐骨神经测量强直张力输出。通过荧光免疫组织化学分析植入的绿色荧光蛋白(GFP)阳性组织和细胞的行为。结果。SP短期恢复组相对于对侧显示平均肌肉质量恢复64%,强直张力输出恢复36%。然后,SP长期恢复组显示平均肌肉质量(77%)和强直张力输出(49%)的恢复增加。然而,对照组在肌肉和肌腱之间未显示连续性恢复,且在术后4 - 8周内肌肉萎缩增加,并与胫骨融合。组织学证据也支持SP组的上述功能恢复。植入的Sk-MSCs主要形成包括神经血管网络在内的结缔组织和肌纤维,并桥接断裂的肌腱 - 肌纤维单元,分化为骨骼肌细胞、雪旺细胞、血管平滑肌和内皮细胞。讨论。Sk-MSC片丸作为一种“生物粘合剂”,其在肌腱和肌纤维之间的这种桥接能力代表了一种治疗术后各种MTJ断裂的可能方法。